Abcam

About:

Abcam helps researches with breakthroughs in areas such as cancer, neurological disorders, infectious diseases, and metabolic disorders.

Website: http://www.abcam.com

Twitter/X: abcam

Top Investors: HSBC

Description:

Abcam helps researches with breakthroughs in areas like cancer, neurological disorders, infectious diseases, and metabolic disorders.

Total Funding Amount:

$336M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Cambridge, Cambridgeshire, United Kingdom

Founded Date:

1998-01-01

Contact Email:

orders(AT)abcam.com

Founders:

David Cleevely, Jonathan Milner, Tony Kouzarides

Number of Employees:

1001-5000

Last Funding Date:

2019-05-15

IPO Status:

Delisted

© 2025 bioDAO.ai